GO2 PRECISE

Petty, Russell (Investigator)

Molecular and Clinical Medicine

Status	Active
Effective start/end date	1/03/20 → 28/02/23

Funding

Cancer Research UK (C22029/A29637): £286,270.00

1 Article

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial
GO2 Trial Investigators, Hall, P. S., Swinson, D., Cairns, D. A., Waters, J. S., Petty, R., Allmark, C., Ruddock, S., Falk, S., Wadsley, J., Roy, R., Tillett, T., Nicoll, J., Cummins, S., Mano, J., Grumett, S., Stokes, Z., Konstantinos-Velios, K., Chatterjee, A., Garcia, A. & 15 others, Waddell, T., Guptal, K., Maisey, N., Khan, M., Dent, J., Lord, S., Crossley, A., Katona, E., Marshall, H., Grabsch, H. I., Velikova, G., Ow, P. L., Handforth, C., Howard, H. & Seymour, M. T., Jun 2021, In: JAMA Oncology. 7, 6, p. 869-877 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
8 Downloads (Pure)